Caldera Health asks men to give biopsy samples to help prove up prostate cancer test

Tue, 08 Sep 2015

By Fiona Rotherham Sept. 8 (BusinessDesk) - Caldera Health, a New Zealand biotech company working on a gene-sequencing replacement for the world’s most widely used prostate cancer test, is seeking more biopsy samples from Kiwi men to help prove its concept. Caldera managing director Graham Watt said he wants at least 50 samples by the end of the year though would eventually like to build up to at least 200 to help prove the credibility of its proprietary gene-sequencing test. The medical diagnostic firm has been receiving a few samples...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Markets
Govt invests $30m with coastal shipping 'winners'
Brent Melville | Wed, 25 May 2022

Government investment is seen as the starting point to creating a viable coastal shipping sector.

Media
Media firms adapt to avoid poaching
Daniel Dunkley | Wed, 25 May 2022

They call it the Great Resignation – a global phenomenon which has seen people leave their jobs in their droves since the pandemic. But in competitive sectors like advertising and communications, firms are fighting back.

Tourism
Are hotel prices 'courageous' or outrageous?
Brent Melville | Wed, 25 May 2022

Tourists can expect to see a jump in their hotel bills on the back of reduced availability, and as the industry scrambles to reinvent itself after a two-year hiatus.

Partner content
Small business lessons for attracting and retaining staff

Employers battling through the ‘Great Resignation’ are now faced with the ‘Great Brain Drain’.

Partner content
People leaders are key to wellbeing but still need help

One in three people say they have experienced an issue with an unsupportive manager